Andrea Mambrini

Andrea Mambrini is the CTO & Co-Founder of Exogene Ltd., a biotechnology startup focused on developing TCR-based therapies for cancer treatment using deep learning.12 Mambrini co-founded Exogene in 2019 and has since been serving as its CTO.1

With a strong background in computer science and engineering, Mambrini holds a Ph.D. in Bio-Inspired Computation from the University of Birmingham, completed in 2015.13 He is described as an experienced machine learning scientist with several years of experience building AI systems.2

Prior to founding Exogene, Mambrini had a diverse career in data science and AI:

• Senior Data Scientist and AI Expert at Vodafone (2019)
• Data Scientist Contractor at Black Swan Data (2018)
• Lead Data Scientist at Creative AI and Portent.io (2015-2017)
• Research Associate at the University of Sheffield (2015)
• Research Intern at Honda Research Institute Europe GmbH (2014)
• Visiting Researcher at Nanjing University (2014)
• Software Engineer at the European Space Agency - Advanced Concepts Team (2013)1

Mambrini's academic achievements include a Bachelor of Science in Information Engineering and a Master of Science in Computer Engineering from Università degli Studi di Padova.1 He has also received several honors, including nominations for best paper awards at academic conferences and being a finalist for the UK ICT Pioneer Award in 2015.3

At Exogene, Mambrini is likely applying his expertise in AI and machine learning to develop the company's generative AI platform for TCR discovery, which aims to identify novel, high-affinity, and non-cross-reactive TCRs for cancer treatment.2